Cite

HARVARD Citation

    Mansouri, A. et al. (2021). Randomised phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol. BMJ open. 11 (1), p. . [Online]. 
  
Back to record